150 related articles for article (PubMed ID: 2143954)
1. Development of tolerance to donor type and host type H-2 antigens following transplantation of allogeneic bone marrow in mice.
Levite M; Reisner Y
Bone Marrow Transplant; 1990 Jul; 6(1):37-44. PubMed ID: 2143954
[TBL] [Abstract][Full Text] [Related]
2. A study on proliferative responses to host Ia antigens in allogeneic bone marrow chimera in mice: sequential analysis of the reactivity and characterization of the cells involved in the responses.
Iwabuchi K; Ogasawara K; Ogasawara M; Yasumizu R; Noguchi M; Geng L; Fujita M; Good RA; Onoé K
J Immunol; 1987 Jan; 138(1):18-25. PubMed ID: 2946776
[TBL] [Abstract][Full Text] [Related]
3. Bone marrow-derived cells are essential for intrathymic deletion of self-reactive T cells in both the host- and donor-derived thymocytes of fully allogeneic bone marrow chimeras.
Yoshikai Y; Ogimoto M; Matsuzaki G; Nomoto K
J Immunol; 1990 Jul; 145(2):505-9. PubMed ID: 2114441
[TBL] [Abstract][Full Text] [Related]
4. Long-term immunologic tolerance induction in chimeric mice after bone marrow transplantation across major histocompatibility barriers: persistent or redeveloping immunologic responsiveness after prolonged survival.
Sugiura K; Yasumizu R; Iwai H; Inaba MM; Toki J; Ogura M; Hara I; Good RA; Ikehara S
Thymus; 1991 Nov; 18(3):137-53. PubMed ID: 1838450
[TBL] [Abstract][Full Text] [Related]
5. Intrathymic T cell differentiation in radiation bone marrow chimeras and its role in T cell emigration to the spleen. An immunohistochemical study.
Hirokawa K; Sado T; Kubo S; Kamisaku H; Hitomi K; Utsuyama M
J Immunol; 1985 Jun; 134(6):3615-24. PubMed ID: 2859334
[TBL] [Abstract][Full Text] [Related]
6. Role of intrathymic clonal deletion and peripheral anergy in transplantation tolerance induced by bone marrow transplantation in mice conditioned with a nonmyeloablative regimen.
Tomita Y; Khan A; Sykes M
J Immunol; 1994 Aug; 153(3):1087-98. PubMed ID: 8027542
[TBL] [Abstract][Full Text] [Related]
7. Studies of immunologic tolerance to host minor histocompatibility antigens following allogeneic bone marrow transplantation in mice.
Perreault C; Allard A; Brochu S; Poupart C; Fontaine P; Bélanger R; Gyger M
Bone Marrow Transplant; 1990 Aug; 6(2):127-35. PubMed ID: 2145050
[TBL] [Abstract][Full Text] [Related]
8. Induction of stable long-term mixed hematopoietic chimerism following nonmyeloablative conditioning with T cell-depleting antibodies, cyclophosphamide, and thymic irradiation leads to donor-specific in vitro and in vivo tolerance.
Mapara MY; Pelot M; Zhao G; Swenson K; Pearson D; Sykes M
Biol Blood Marrow Transplant; 2001; 7(12):646-55. PubMed ID: 11787527
[TBL] [Abstract][Full Text] [Related]
9. [A study of proliferative responses to host Ia antigens in fully allogeneic bone marrow chimeras in mice--sequential analysis of the reactivity and characterization of the cells involved in the response].
Iwabuchi K
Hokkaido Igaku Zasshi; 1986 Nov; 61(6):869-82. PubMed ID: 3493963
[TBL] [Abstract][Full Text] [Related]
10. Recovery from established graft-vs-host disease achieved by bone marrow transplantation from a third-party allogeneic donor.
Taniguchi Y; Yoshihara S; Hoshida Y; Inoue T; Fujioka T; Ikegame K; Kawakami M; Masuda T; Aozasa K; Kawase I; Ogawa H
Exp Hematol; 2008 Sep; 36(9):1216-25. PubMed ID: 18599183
[TBL] [Abstract][Full Text] [Related]
11. Mixed allogeneic chimeras prepared by a non-myeloablative regimen: requirement for chimerism to maintain tolerance.
Sharabi Y; Abraham VS; Sykes M; Sachs DH
Bone Marrow Transplant; 1992 Mar; 9(3):191-7. PubMed ID: 1387333
[TBL] [Abstract][Full Text] [Related]
12. Role of the thymus in control of autoreactivity or allotolerance in syngeneic and allogeneic bone marrow chimeras treated with bacterial adjuvants.
Taniguchi K; Gondo H; Nomoto K
J Immunol; 1984 Oct; 133(4):1735-9. PubMed ID: 6088626
[TBL] [Abstract][Full Text] [Related]
13. Effect of selective T cell depletion of host and/or donor bone marrow on lymphopoietic repopulation, tolerance, and graft-vs-host disease in mixed allogeneic chimeras (B10 + B10.D2----B10).
Ildstad ST; Wren SM; Bluestone JA; Barbieri SA; Stephany D; Sachs DH
J Immunol; 1986 Jan; 136(1):28-33. PubMed ID: 2933464
[TBL] [Abstract][Full Text] [Related]
14. Graft-versus-leukemia effects from donor lymphocyte infusion after nonmyeloablative allogeneic bone marrow transplantation in mice.
Du B; Li DP; Xu KL; Pan XY
Chin Med J (Engl); 2005 Mar; 118(6):474-9. PubMed ID: 15788128
[TBL] [Abstract][Full Text] [Related]
15. Tolerance to host minor histocompatibility antigens after allogenic bone marrow transplantation. Specific donor-host unresponsiveness is maintained by peripheral tolerizing cells.
Brochu S; Roy DC; Perreault C
J Immunol; 1992 Nov; 149(10):3135-41. PubMed ID: 1431092
[TBL] [Abstract][Full Text] [Related]
16. Delayed infusion of normal donor cells after MHC-matched bone marrow transplantation provides an antileukemia reaction without graft-versus-host disease.
Johnson BD; Drobyski WR; Truitt RL
Bone Marrow Transplant; 1993 Apr; 11(4):329-36. PubMed ID: 8485480
[TBL] [Abstract][Full Text] [Related]
17. Graft-facilitating doses of ex vivo activated gammadelta T cells do not cause lethal murine graft-vs.-host disease.
Drobyski WR; Majewski D; Hanson G
Biol Blood Marrow Transplant; 1999; 5(4):222-30. PubMed ID: 10465102
[TBL] [Abstract][Full Text] [Related]
18. Suppressor T cells in allogeneic bone marrow chimeras.
Leshem B; Lebendiker Z; Weiss L; Slavin S; Kedar E
Bone Marrow Transplant; 1987 Aug; 2(2):123-32. PubMed ID: 2901877
[TBL] [Abstract][Full Text] [Related]
19. Analysis of tolerance induction using triple chimeric mice: major histocompatibility complex-disparate thymus, hemopoietic cells, and microenvironment.
Cui W; Hosaka N; Miyake T; Wang X; Guo K; Cui Y; Li Q; Song C; Feng W; Li Q; Takaki T; Nishida T; Inaba M; Ikehara S
Transplantation; 2008 Apr; 85(8):1151-8. PubMed ID: 18431236
[TBL] [Abstract][Full Text] [Related]
20. Oligoclonal expansion of CTLs directed against a restricted number of dominant minor histocompatibility antigens in hemopoietic chimeras.
Brochu S; Baron C; Hétu F; Roy DC; Perreault C
J Immunol; 1995 Dec; 155(11):5104-14. PubMed ID: 7594519
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
